131 related articles for article (PubMed ID: 3898139)
1. Methotrexate for superficial bladder cancer.
Hall RR
Prog Clin Biol Res; 1985; 185B():143-9. PubMed ID: 3898139
[No Abstract] [Full Text] [Related]
2. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
3. Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078).
Simone G; Leonardo C; Gallucci M
Urology; 2008 Nov; 72(5):1187-8. PubMed ID: 18774592
[No Abstract] [Full Text] [Related]
4. Maintenance therapy for superficial bladder cancer.
Baselli EC; Greenberg RE
Oncology (Williston Park); 2001 Jan; 15(1):85-8; discussion 88-91. PubMed ID: 11271984
[TBL] [Abstract][Full Text] [Related]
5. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of methotrexate in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Hamsa R; Cairns J; Anderson T; Ziegler JL
Cancer Treat Rep; 1978 Jul; 62(7):1075-6. PubMed ID: 356969
[No Abstract] [Full Text] [Related]
7. Prophylactic oral methotrexate therapy for multiple superficial bladder carcinoma.
Hall RR; Herring DW; Gibb I; Heath AB
Br J Urol; 1981 Dec; 53(6):582-4. PubMed ID: 7317746
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
Kurth KH; Debruyne FJ; Senge T; Carpentier PJ; Riedl H; Sylvester R; de Pauw M
Prog Clin Biol Res; 1985; 185B():135-42. PubMed ID: 3898138
[No Abstract] [Full Text] [Related]
9. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Bouffioux C
Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
[No Abstract] [Full Text] [Related]
10. Intravesical treatment with thiotepa: an update review.
Fosså SD
Prog Clin Biol Res; 1984; 162B():163-8. PubMed ID: 6438640
[No Abstract] [Full Text] [Related]
11. Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.
Oliver RT; England HR; Risdon RA; Blandy JP
J Urol; 1984 Mar; 131(3):483-5. PubMed ID: 6230463
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of bladder neoplasms--studies of preventive measures against recurrence of superficial bladder neoplasms].
Okajima E; Motomiya Y; Ishuin M; Ikuma S; Ohara S
Nihon Rinsho; 1977 May; 35(5):1987-91. PubMed ID: 407385
[No Abstract] [Full Text] [Related]
13. Chemotherapy of metastatic bladder cancer.
Yagoda A
Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
[No Abstract] [Full Text] [Related]
14. [International Consensus Panel--treatment strategies for superficial bladder cancer].
Adler S; St Niclas M
Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
[No Abstract] [Full Text] [Related]
15. [The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)].
Bocharova OA; Matveev BP; Baryshnikov AIu; Figurin KM; Serebriakova RV; Bodrova NB
Urol Nefrol (Mosk); 1995; (2):46-7. PubMed ID: 7785120
[TBL] [Abstract][Full Text] [Related]
16. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
17. The Nb rat transitional cell bladder carcinoma model: dose response to methotrexate and adriamycin.
Drago JR; Nesbitt JA
Anticancer Res; 1986; 6(5):1019-20. PubMed ID: 3800312
[TBL] [Abstract][Full Text] [Related]
18. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
Flüchter SH; Harzmann R; Erdmann D; Bichler KH
Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
[No Abstract] [Full Text] [Related]
19. [A case report of a young patient with invasive bladder cancer].
Nakashima M; Nishiyama H; Yagihashi Y; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Hinyokika Kiyo; 2003 Dec; 49(12):745-8. PubMed ID: 14978958
[TBL] [Abstract][Full Text] [Related]
20. Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2.
Grasso M; Torelli F; Scannapieco G; Franzoso F; Lania C
J Immunother; 2001; 24(2):184-7. PubMed ID: 11265776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
